Renal Hemodynamics Completed Phase 1 Trials for Naproxcinod (DB06682)

IndicationStatusPhase
DBCOND0043691 (Renal Hemodynamics)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00909519Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of FurosemideBasic Science